Afuco™ Anti-BSG ADCC Therapeutic Antibody (Gavilimomab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD147. Gavilimomab (also known as ABX-CBL) is a mouse monoclonal antibody intended for use as an immunosuppressive biologic treatment of glucocorticoid-resistant graft versus host disease. It binds to the antigen CD147. Gavilimomab proved slightly less effective than standard antithymocyte globulin therapy.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-156 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | BSG |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FuncS, IF, Neut, ELISA, FC, IP |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |